Antibiotic In Vitro Data Needed In Labeling For Appropriate Use, PhRMA Says

Removal of in vitro susceptibility data from anti-infective drug labeling could cause an escalation in inappropriate antibiotic use, the Pharmaceutical Research & Manufacturers of America said in comments on FDA's proposed drug labeling rule.